Eli Lilly Stock Falls as Mounjaro Sales Fall Short. Earnings Still Crushed.

Eli Lilly

stock was falling Thursday as sales in the pharmaceutical company’s much-hyped obesity drug came up short. Fourth-quarter earnings, however, did crush estimates.

Shares in

Eli Lilly

(ticker: LLY) fell 2.9% in premarket trading. Futures tracking the

S&P 500

were rising 0.5%, by comparison.